Pricing Log in Create free account

Pyxis Oncology, Inc. (PYXS) vs Sol-Gel Technologies Ltd. (SLGL)

Pyxis Oncology, Inc. and Sol-Gel Technologies Ltd. are both Biotechnology companies. Pyxis Oncology, Inc. and Sol-Gel Technologies Ltd. are of similar size ($224.9M and $215.3M). Pyxis Oncology, Inc. has the higher net margin (0.00% vs −910.1%) and the higher return on invested capital (0.00% vs −6,630.2%). Across the 13 metrics below, Sol-Gel Technologies Ltd. leads on 8 and Pyxis Oncology, Inc. on 5.

Valuation

Metric PYXS SLGL Biotechnology median
P/E n/m n/m 8.50
P/S n/m 117.08 9.71
P/B 9.34 4.37 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales n/m 126.78 9.21
Earnings yield (84.43%) (8.78%) (33.15%)
Free cash flow yield (63.55%) (10.12%) (25.50%)

Profitability

Metric PYXS SLGL Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% (986.96%) 0.00%
Net margin 0.00% (910.14%) 0.00%
Free cash flow margin 0.00% (1,185.18%) 0.00%
Return on equity (179.10%) (40.85%) (56.36%)
Return on assets (99.62%) (35.11%) (48.04%)
Return on invested capital 0.00% (6,630.24%) 0.00%

Growth

Metric PYXS SLGL Biotechnology median
Revenue growth (TTM) — (92.50%) 6.02%
EPS growth (last fiscal year) 3.03% 42.37% 30.26%
Revenue growth, 5-year CAGR — 17.19% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric PYXS SLGL Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 1.34 10.37 4.72
Net debt to EBITDA 0.82 3.23 0.96

Dividend

Metric PYXS SLGL Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric PYXS SLGL Biotechnology median
Market cap 215.25m 224.92m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack